Clinical Trial

Antarctic Krill Oil for Knee Osteoarthritis Pain

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the effectiveness and safety of Antarctic Krill Oil (AKO) as a dietary supplement in managing pain associated with knee osteoarthritis (OA). The main questions it aims to answer are: ①Does AKO reduce daily pain intensity in participants with moderate knee OA? ②What adverse effects do participants experience when taking AKO? Researchers will conduct a randomized, double-blind study comparing AKO to a placebo (identical appearance without active components) to assess: * Changes in joint pain severity; ②Functional improvement in daily activities; ③Biochemical safety parameters,etc.
Trial Details
NCT Number NCT06880926
Lead Sponsor Qilu Hospital of Shandong University
Conditions Osteoarthritis (OA) of the Knee, Osteoarthritis Knee Pain
Enrollment 116 participants
Start Date 2025-04-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-03-18